Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
49
EXAS Quote, Financials, Valuation and Earnings
Last price:
$103.30
Seasonality move
:
3.51%
Day range:
$103.21 - $103.41
52-week range:
$38.81 - $103.54
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.01x
P/B ratio:
8.18x
Volume:
2.3M
Avg. volume:
2.3M
1-year change:
104.62%
Market cap:
$19.6B
Revenue:
$3.2B
EPS (TTM):
-$1.10
Analysts' Opinion
-
Consensus RatingEXACT Sciences Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 20 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $105.81, EXACT Sciences Corp. has an estimated upside of 2.37% from its current price of $103.29.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $105.00 representing -1.59% downside risk from its current price of $103.29.
Fair Value
-
According to the consensus of 21 analysts, EXACT Sciences Corp. has 2.37% upside to fair value with a price target of $105.81 per share.
EXAS vs. S&P 500
-
Over the past 5 trading days, EXACT Sciences Corp. has underperformed the S&P 500 by -0.65% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
EXACT Sciences Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
EXACT Sciences Corp. has grown year-over-year revenues for 41 quarters straight. In the most recent quarter EXACT Sciences Corp. reported revenues of $878.4M.
Earnings Growth
-
EXACT Sciences Corp. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter EXACT Sciences Corp. reported earnings per share of -$0.45.
Enterprise value:
21.2B
EV / Invested capital:
4.30x
Price / LTM sales:
6.01x
EV / EBIT:
--
EV / Revenue:
6.53x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
59.42x
Price / Operating cash flow:
54.66x
Enterprise value / EBITDA:
321.70x
Gross Profit (TTM):
$2.3B
Return On Assets:
-3.51%
Net Income Margin (TTM):
-6.4%
Return On Equity:
-8.54%
Return On Invested Capital:
-4.14%
Operating Margin:
-8.73%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $2.5B | $2.8B | $3.2B | $713.4M | $878.4M | |
| Gross Profit | $1.8B | $1.9B | $2.3B | $492.6M | $615.8M | |
| Operating Income | -$305M | -$200.4M | -$155.7M | -$41.8M | -$76.7M | |
| EBITDA | -$77.5M | $14.5M | $65.9M | $11.4M | -$20.3M | |
| Diluted EPS | -$1.14 | -$5.56 | -$1.10 | -$4.67 | -$0.45 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.4B | $982.3M | $1.2B | $1.6B | $1.6B | |
| Total Assets | $7.2B | $6.7B | $6.9B | $6.2B | $6.1B | |
| Current Liabilities | $517.1M | $412.7M | $514.7M | $732.2M | $641.2M | |
| Total Liabilities | $3.8B | $3.7B | $3.8B | $3.8B | $3.7B | |
| Total Equity | $3.4B | $3B | $3.1B | $2.4B | $2.4B | |
| Total Debt | $2.4B | $2.4B | $2.5B | $2.7B | $2.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $156.1M | $210.5M | $491.4M | $47.1M | $151.7M | |
| Cash From Investing | $49.7M | -$442.2M | $195.1M | -$41.9M | $91.1M | |
| Cash From Financing | $159.8M | $231.9M | -$338.1M | $10.5M | -$75.9M | |
| Free Cash Flow | $31.9M | $74.5M | $356.8M | $55.7M | $120.4M | |
EXAS
Sector
Market Cap
$19.6B
$25.8M
Price % of 52-Week High
99.83%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
0.11%
-1.67%
1-Year Price Total Return
108.26%
-21.92%
Beta (5-Year)
1.416
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$103.32
200-day SMA
Buy
Level
$69.24
Bollinger Bands (100)
Buy
Level
67.52 - 106.16
Chaikin Money Flow
Buy
Level
35.4M
20-day SMA
Buy
Level
$102.80
Relative Strength Index (RSI14)
Buy
Level
72.42
ADX Line
Buy
Level
51.68
Williams %R
Sell
Level
-12.6316
50-day SMA
Buy
Level
$102.19
MACD (12, 26)
Buy
Level
0.67
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
345.3M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7195)
Sell
CA Score
(Annual)
Level (-0.8266)
Buy
Beneish M-Score
(Annual)
Level (-2.852)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (2.4981)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.
Stock Forecast FAQ
In the current month, EXAS has received 1 Buy ratings 20 Hold ratings, and 0 Sell ratings. The EXAS average analyst price target in the past 3 months is $105.81.
-
Where Will EXACT Sciences Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that EXACT Sciences Corp. share price will rise to $105.81 per share over the next 12 months.
-
What Do Analysts Say About EXACT Sciences Corp.?
Analysts are divided on their view about EXACT Sciences Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that EXACT Sciences Corp. is a Sell and believe this share price will drop from its current level to $105.00.
-
What Is EXACT Sciences Corp.'s Price Target?
The price target for EXACT Sciences Corp. over the next 1-year time period is forecast to be $105.81 according to 21 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 20 analysts rate the stock a Hold.
-
Is EXAS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for EXACT Sciences Corp. is a Hold. 20 of 21 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of EXAS?
You can purchase shares of EXACT Sciences Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase EXACT Sciences Corp. shares.
-
What Is The EXACT Sciences Corp. Share Price Today?
EXACT Sciences Corp. was last trading at $103.30 per share. This represents the most recent stock quote for EXACT Sciences Corp.. Yesterday, EXACT Sciences Corp. closed at $103.29 per share.
-
How To Buy EXACT Sciences Corp. Stock Online?
In order to purchase EXACT Sciences Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get EXAS Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EXAS
Sector
P/E ratio
--
23.35x
PEG ratio
-0.05x
-0.01x
P/B ratio
8.18x
1.78x
Price / LTM sales
6.01x
1.55x
Growth Metrics
EXAS
Sector
Revenue growth
23.12%
3.74%
Earnings growth
90.29%
11.14%
Revenue (5-year growth)
16.84%
6.38%
Earnings forecast
$0.08
-$0.19
Profitability
EXAS
Sector
Profitability FY 2025
$2.3B
$2.6M
Return on invested capital
-4.14%
-32.91%
Return on assets
-3.51%
-29.56%
Return on equity
-8.54%
-38.66%
Earnings Date
Last Earnings Date
Feb
13
Next Earnings Date
May
7
Estimated Next Earnings Date
May
15
Balance Sheet
EXAS
Sector
Total cash
$964.7M
$25.2M
Short term investments
$437.1M
$24.1M
Total assets
$6.1B
$72.8M
Long term debt
$2.5B
$2.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Sell
49
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
46
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
73
HYMC alert for Feb 20
Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.
Buy
57
GLBE alert for Feb 20
Global-e Online Ltd. [GLBE] is up 4.19% over the past day.
Sell
37
ACLS alert for Feb 20
Axcelis Technologies, Inc. [ACLS] is down 1.71% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
